Mobility, ICT, and health: a built environment investigation of older Chinese migrants’ social isolation and loneliness.

Publication date: Feb 07, 2025

Social isolation and loneliness have detrimental impacts on health, especially for older adults. During the COVID-19 pandemic, physical access to third places (e. g., coffee shops, libraries) decreased due to the closure of non-essential destinations and personal risk assessments. Older adults reported adopting information and communication technology (ICT) during pandemic lockdowns. ICT-mediated socializing may have different impacts on loneliness than in-person equivalents. Understanding access to social connection and their distinct relationships to the built environment and health for older Chinese migrants is critical to supporting equitable, healthy aging in a post-COVID world. Using a survey of older Chinese migrants in the Greater Toronto Area (GTA) during the extended COVID-19 lockdown, we investigate how community mobility and ICT use, two mechanisms of socializing, relate to the built environment and influence loneliness (De Jong Gierveld 6-item scale), as well as mental and physical health (SF-12). Specifically, we use a structural equation model to test a theoretical framework of older adult social isolation. Our model demonstrates the importance of community mobility for reducing feelings of loneliness, while ICT use is significantly related to better physical health. Both community mobility and ICT use have significant, although opposite, relationships to transit density. Results indicate that ICT use might have limited ability to reduce loneliness and support mental health when mobility is limited. Addressing older migrants’ barriers to community mobility is critical to reducing feelings of loneliness.

Open Access PDF

Concepts Keywords
Chinese ICT
Libraries Loneliness
Loneliness Mental health
Socializing Migrants
Toronto Mobility
Older adults
Physical Health
Social isolation

Semantics

Type Source Name
disease MESH loneliness
disease MESH COVID-19 pandemic
drug DRUGBANK 7-Methyl-Gpppa
drug DRUGBANK Tropicamide
pathway REACTOME Reproduction
drug DRUGBANK Amber
disease IDO country
drug DRUGBANK Trestolone
drug DRUGBANK Diethylstilbestrol
disease MESH social stigma
drug DRUGBANK Coenzyme M
disease MESH cognitive impairment
disease MESH anxiety
drug DRUGBANK Creatinolfosfate
drug DRUGBANK Methylergometrine
disease MESH Marital status
drug DRUGBANK Ademetionine

Original Article

(Visited 3 times, 1 visits today)